Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 340-343, 2013.
Article in Chinese | WPRIM | ID: wpr-301472

ABSTRACT

<p><b>OBJECTIVE</b>The aim of this study was to describe a new technique of combined hyoid bone and thyrohyoid membrane flap in laryngeal reconstruction after tumor resection, and to evaluate outcome.</p><p><b>METHODS</b>Six patients requiring an frontal partial laryngectomy for cancer were enrolled between September 2008 and August 2012.</p><p><b>RESULTS</b>Nasogastric feeding was initiated within 24 hours. The mean times to swallow batter, ability to drink water and removal of the nasogastric tube were 2.6, 5.5 and 6.3 days. All patients had good respiratory function. There were no deaths, and no reports of postoperative dyspnea or dysphagia. The vocal quality was satisfactory, slightly deeper and raspy, and the volume was weak when calling. The final follow-up assessment was in August 2012, and the overall mean follow-up period was 29.5months, range 14 to 47 months. Case two subsequently underwent total laryngectomy for recurrence in the paraglottic space, but there was no evidence of further tumor recurrence at the final assessment.</p><p><b>CONCLUSIONS</b>The combined muscle-pedicle hyoid bone and thyrohyoid membrane flap is a reliable graft for one-stage repair of laryngotracheal defects, providing effective repair of the mucosa and cartilage support. Vocal quality, swallowing function and ventilation after the procedure were favorable.</p>


Subject(s)
Humans , Hyoid Bone , General Surgery , Laryngeal Neoplasms , General Surgery , Laryngectomy , Methods , Laryngoplasty , Methods , Larynx , General Surgery , Surgical Flaps
2.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 934-938, 2013.
Article in Chinese | WPRIM | ID: wpr-271641

ABSTRACT

<p><b>OBJECTIVE</b>Hypoparathyroidism is one of the most serious complications of thyroidectomy. It is important to identify the parathyroid glands during thyroidectomy. In order to find an economic, simple and less traumatic way to identify the parathyroid glands and testify its feasibility, fine-needle aspiration of suspected parathyroid tissue was used to measure the parathyroid hormone (PTH) levels during the surgical procedure.</p><p><b>METHODS</b>From Nov. 2011 to Apr. 2012, 50 patients were recruited for thyroid surgery in the Sun Yat-sen University Cancer Centre. During surgery, fine-needle aspiration of suspected tissues, including parathyroid gland, thyroid gland, muscle, fat tissue, and lymph node, was performed, the PTH levels were measured. In addition, the tissues above-mentioned were taken to pathological examination. Statistical processing was adopted to determine the sensitivity and specificity of intraoperative fine-needle aspiration with measurement of PTH level in finding the pathology of the parathyroid gland.</p><p><b>RESULTS</b>There were 237 tissues from 50 patients in total, and 45 of them were certified as the parathyroid glands by pathology. Intra-operative PTH (ioPTH) of the tissues in forty-four cases were higher than 600 ng/L, ioPTH of the tissues in one case was lower than 600 ng/L, and it was 160 ng/L. The highest ioPTH in other cases was 537.7 ng/L. The sensitivity was 97.8%. The specificity was 100%. The difference between the sensitivity and the specificity of two groups was not statistically significant, and P > 0.05. The level of PTH of parathyroid gland were much higher than other tissues, and P < 0.001.</p><p><b>CONCLUSIONS</b>The level of ioPTH of parathyroid gland were far higher than thyroid, muscle, fat, lymph node. It is an economic, fast and less traumatic way to identify the parathyroid gland by using the fine-needle aspiration of the parathyroid tissue with measurement of PTH levels. The sensitivity and the specificity are high. It can be used in the thyroidectomy to identify the parathyroid glands.</p>


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Young Adult , Biopsy, Fine-Needle , Methods , Parathyroid Glands , Chemistry , Pathology , General Surgery , Parathyroid Hormone , Sensitivity and Specificity , Thyroidectomy
3.
Chinese Journal of Stomatology ; (12): 528-530, 2011.
Article in Chinese | WPRIM | ID: wpr-306395

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the treatment and prognosis of the patients with oral mucosal melanoma (OMM).</p><p><b>METHODS</b>The clinicopathological and follow-up data of patients with OMM in Sun Yat-sen University Cancer Center from January 1976 to December 2005 were analyzed retrospectively.</p><p><b>RESULTS</b>Fifty-one cases were analyzed. The pathological lymph node metastasis rate was 61% (31/51) and the affected sites were confined to level I(b)-III (94%). The overall three year and five yearsurvival rates were 35% and 21% respectively. No significant difference of three year and five year survival rates were found between the group of incisional biopsy and the group of excisional biopsy. The prognosis was not affected by pigmentation. The survival rate of the patients receiving surgery combined with biotherapy or biochemotherapy was significantly higher than that of the patients treated by other modalities (P = 0.003).</p><p><b>CONCLUSIONS</b>In patients with OMM, lymph node metastasis was mostly confined to level I(b)-III. Incisional biopsy and pigmentation were not associated with an unfavorable prognosis. The prognosis of the patients with OMM was poor and the patients may get a better prognosis by receiving surgery combined with biotherapy or biochemotherapy.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Antineoplastic Combined Chemotherapy Protocols , Therapeutic Uses , BCG Vaccine , Therapeutic Uses , Combined Modality Therapy , Follow-Up Studies , Interferon-gamma , Therapeutic Uses , Interleukin-2 , Therapeutic Uses , Lung Neoplasms , Lymph Node Excision , Lymphatic Metastasis , Melanoma , Drug Therapy , Pathology , General Surgery , Melanoma-Specific Antigens , Metabolism , Mouth Mucosa , Pathology , General Surgery , Mouth Neoplasms , Drug Therapy , Pathology , General Surgery , Retrospective Studies , S100 Proteins , Metabolism , Survival Rate
4.
Chinese Medical Journal ; (24): 1157-1161, 2009.
Article in English | WPRIM | ID: wpr-292749

ABSTRACT

<p><b>BACKGROUND</b>Airway remodeling is the specific pathological characteristics of asthma, which is related to the clinical symptoms, pulmonary function, and airway hyperreactivity. This study aimed at exploring the effects of dermatophagoides pteronyssinus allergen-specific immunotherapy (SIT) on the serum interleukin (IL)-13 and pulmonary functions in asthmatic children.</p><p><b>METHODS</b>Fifty-eight pediatric asthma patients allergic to dust mite participated in this study. Thirty-five children received SIT with a standardized dermatophagoides pteronyssinus extract for one year (SIT group), and the other 23 children treated with inhaled corticosteroids (ICS group) according to the Global Initiative for Asthma (GINA) for one year. Serum levels of IL-13, IL-4 and interferon (IFN)-gamma were examined and the pulmonary functions were checked before and after the treatment.</p><p><b>RESULTS</b>After the treatment, the number of emergency visiting for asthma attack in SIT group was significantly less than that in ICS group. The serum levels of IL-4 and IL-13 were clearly reduced, IFN-gamma and the ratio of IFN-gamma/IL-4 were significantly increased, the pulmonary functions (forced vital capacity (FVC), forced expiratory volume in one second percentage (FEV(1)%) and peak expiratory flow percentage (PEF%) were significantly improved in the SIT group. Meanwhile, IFN-gamma and the ratio of IFN-gamma/IL-4 were greatly increased, but serum levels of IL-4 and IL-13 had less changes, the pulmonary functions (FVC, FEV(1)% and PEF%) were poorly improved in ICS group. The basic pulmonary functions in both groups were at the same level, which had made more improvement in SIT group than in ICS group one year later.</p><p><b>CONCLUSIONS</b>One year of dermatophagoides pteronyssinus SIT can significantly reduce the frequencies of emergency visiting for asthma attack and improve the pulmonary functions of children with allergic asthma, and that is attributed to SIT, which can reduce the levels of IL-4 and IL-13 and regulate the imbalance of the Th1/Th2 cells in asthmatic children. All of these might be effective in preventing the asthmatic airway from remodeling.</p>


Subject(s)
Adolescent , Animals , Child , Child, Preschool , Female , Humans , Male , Antigens, Dermatophagoides , Allergy and Immunology , Asthma , Blood , Allergy and Immunology , Therapeutics , Dermatophagoides pteronyssinus , Allergy and Immunology , Enzyme-Linked Immunosorbent Assay , Immunotherapy , Methods , Interferon-gamma , Blood , Interleukin-13 , Blood , Interleukin-4 , Blood
5.
Journal of Southern Medical University ; (12): 1179-1181, 2009.
Article in Chinese | WPRIM | ID: wpr-282588

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of Dermatophagoides pteronyssinus allergen-specific immunotherapy (SIT) on the prognosis of asthmatic children.</p><p><b>METHODS</b>Sixty-five children with established diagnosis of allergic asthma to dust mite were enrolled in this study, of whom 42 children received treatment with standardized SIT for 12 month and the other 23 served as the control group with inhaled corticosteroids according to Global Initiative for Asthma (GINA). The serum levels of interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) were detected and the pulmonary functions examined before and after the one-year treatment in all the patients.</p><p><b>RESULTS</b>After the one-year treatment with SIT, the asthmatic children showed obviously reduced serum levels of IL-4, significantly increased IFN-gamma levels and the IFN-gamma/IL-4 ratio (P<0.05), and markedly improved pulmonary functions (FVC, pre-FEV1% and pre-PEF%) (P<0.05). In the control group, the children exhibited significantly increased IFN-gamma levels and IFN-gamma/ IL-4 ratio (P<0.05) without obvious reduction of serum IL-4 levels or pulmonary function improvement (P>0.05). With comparable basic pulmonary functions in the two groups before the treatment, the children in SIT group showed significantly greater improvement in the pulmonary functions than those in the control group after the one-year treatment.</p><p><b>CONCLUSION</b>The one-year treatment with SIT can significantly improve the pulmonary functions of children with allergic asthma, and this effect is attributed to the regulation of Th1/Th2 cell balance and inhibition of asthmatic airway remodeling by SIT.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Allergens , Allergy and Immunology , Antigens, Dermatophagoides , Allergy and Immunology , Asthma , Allergy and Immunology , Therapeutics , Desensitization, Immunologic , Methods , Interferon-gamma , Blood , Interleukin-4 , Blood , Prognosis , Respiratory Function Tests , Th1 Cells , Allergy and Immunology , Th2 Cells , Allergy and Immunology
6.
Chinese Journal of Experimental and Clinical Virology ; (6): 38-40, 2009.
Article in Chinese | WPRIM | ID: wpr-332436

ABSTRACT

<p><b>OBJECTIVE</b>To determine the role of serum leptin in infants with wheezing after respiratory syncytial virus infected.</p><p><b>METHODS</b>43 infants infected with RSV were given blood samples to detect leptin concentration with radioimmunoassays (RIA) within 24 hours after admission into hospital, discharged and 12 weeks later. Then, they were followed up for 2 years. 10 healthy children of the same age served as controls.</p><p><b>RESULTS</b>41.9% infants developed asthma after infected with RSV. Compared to control group, the serum level of leptin in the asthma group and non-asthma group were significantly higher before treatment (t = 3.41 and 2.64 respectively, P < 0.05). When they were discharged, the serum level of leptin in the asthma group was significantly higher than that in non-asthma group and control group (t = 5.74 and 6.23, respectively, P < 0.05). 12 weeks later, the serum level of leptin in the asthma group was still significantly higher than that in non-asthma group and control group (t = 6.32 and 6.11, respectively, P < 0.05), but there were no difference between non-asthma group and control group (t = 0.81, P > 0.05).</p><p><b>CONCLUSION</b>The serum level of leptin in infants with asthma after RSV infected was higher than that in healthy and non-asthma children. Persistent higher level of leptin may play an important role in infants with asthma after RSV infected.</p>


Subject(s)
Child, Preschool , Female , Humans , Infant , Male , Asthma , Blood , Allergy and Immunology , Virology , Case-Control Studies , Follow-Up Studies , Leptin , Blood , Allergy and Immunology , Respiratory Sounds , Allergy and Immunology , Respiratory Syncytial Virus Infections , Blood , Allergy and Immunology , Virology , Respiratory Syncytial Viruses , Allergy and Immunology , Physiology
7.
Chinese Journal of Experimental and Clinical Virology ; (6): 118-120, 2009.
Article in Chinese | WPRIM | ID: wpr-332410

ABSTRACT

<p><b>OBJECTIVE</b>To investigate changes of T lymphocytes subsets in children with infectious mononucleosis (IM) and the effects of different interventions.</p><p><b>METHODS</b>Forty-eight children with IM were enrolled, 28 cases were assigned to the group treated with intravenous immunoglobulin (IVIG) 400 mg/(kg x d) for 5 continuous days or IVIG 1 g/(kg x d) for 2 continuous days, the remaining 20 cases were treated with ganciclovir (GCV) 5-10 mg/(kg x d) for 5 consecutive days. All these children were given general supportive therapies. Twenty healthy children from healthcare clinic serviced as control group.</p><p><b>RESULTS</b>CD4 (%), CD8 (%) and the CD4/CD8 ratio in healthy control group were (34.12 +/- 3.53)%, (26.22 +/- 4.43)% and (1.41 +/- 0.3), in IVIG group were (24.2 +/- 4.3)%, (36.4 +/- 6.8)% and (0.72 +/- 0.12), and in GCV group were (23.7 +/- 5.1)%, (37.3 +/- 7.8)% and (0.67 +/- 0.13), respectively. CD4 (%), CD8 (%) and the ratio CD4/CD8 in the control group were significantly different from those in both groups with IM (P < 0.05). Compared with pre-treatment levels, the 28 cases treated with IVIG had significant improvement, the CD4 (%) increased, CD8 (%) decreased and the ratio of CD4/CD8 increased after treatment (P < 0.05). However, 20 cases in GCV treatment group made less changes (P > 0.05) . Meanwhile, the clinical symptoms and signs in the IVIG group were improved faster than that in the GCV group (P < 0.05). The rate of remission in IVIG group was 88.7% vs. 59.2% of GCV group (P < 0.05); the hospital days in IVIG group were (9.2 +/- 4.3) days vs. (13.8 +/- 5.1) days in the GCV (P < 0.05).</p><p><b>CONCLUSION</b>It is indicated that the subsets of T lymphocytes in peripheral blood are obviously abnormal in children with IM caused by EBV infection in acute phase. IVIG can regulate the immunological derangements of T lymphocytes subsets, on which anti-viral therapy alone may have little impact.</p>


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , CD4-CD8 Ratio , Ganciclovir , Immunoglobulins , Infectious Mononucleosis , Drug Therapy , Allergy and Immunology , T-Lymphocyte Subsets , Allergy and Immunology
8.
Biomedical and Environmental Sciences ; (12): 32-39, 2009.
Article in English | WPRIM | ID: wpr-296007

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the attenuating effect of curcumin, an anti-inflammatory compound derived from dietary spice turmeric (Curcuma longa) on the pro-inflammatory insulin-resistant state in 3T3-L1 adipocytes.</p><p><b>METHODS</b>Glucose uptake rate was determined with the [3H] 2-deoxyglucose uptake method. Expressions of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) were measured by quantitative RT-PCR analysis and ELISA. Nuclear transcription factor kappaB p65 (NF-kappa p65) and mitogen-activated protein kinase (MAPKs) were detected by Western blot assay.</p><p><b>RESULTS</b>The basal glucose uptake was not altered, and curcumin increased the insulin-stimulated glucose uptake in 3T3-L1 cells. Curcumin suppressed the transcription and secretion of TNF-alpha and IL-6 induced by palmitate in a concentration-dependent manner. Palmitate induced nuclear translocation of NF-kappaB. The activities of Jun NH2-terminal kinase (JNK), extracellular signal-regulated kinase1/2 (ERK1/2) and p38MAPK decreased in the presence of curcumin. Moreover, pretreatment with SP600125 (inhibitor of JNK) instead of PD98059 or SB203580 (inhibitor of ERK1/2 or p38MAPK, respectively) decreased the up-regulation of TNF-alpha induced by palmitate.</p><p><b>CONCLUSION</b>Curcumin reverses palmitate-induced insulin resistance state in 3T3-L1 adipocytes through the NF-kappaB and JNK pathway.</p>


Subject(s)
Animals , Mice , 3T3-L1 Cells , Anthracenes , Pharmacology , Anti-Inflammatory Agents, Non-Steroidal , Pharmacology , Curcumin , Pharmacology , Glucose , Metabolism , Insulin , Pharmacology , Insulin Resistance , Interleukin-6 , Genetics , Metabolism , JNK Mitogen-Activated Protein Kinases , Metabolism , MAP Kinase Signaling System , NF-kappa B , Metabolism , Palmitates , Pharmacology , Protein Kinase Inhibitors , Pharmacology , Tumor Necrosis Factor-alpha , Genetics , Metabolism , Up-Regulation
9.
Journal of Southern Medical University ; (12): 470-472, 2008.
Article in Chinese | WPRIM | ID: wpr-293350

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the efficacy of 3 commonly used protocols for management of acute exacerbation of asthma in children.</p><p><b>METHODS</b>Totally 113 asthmatic children were randomized into 3 groups. In group A (53 cases), the children were treated with inhalation of nebulized budesonide suspension plus salbutamol and ipratropium bromide twice daily for 5 days; in group B (41 cases), budesonide plus salbutamol and ipratropium aerosol was administered, and in group C (29 cases), dexathmisone plus aminophylline injection was given once daily for 5 days. All the children received basic treatment with fluid infusion, antibiotics or/and anti-virus medications.</p><p><b>RESULTS</b>The children in both groups A and C showed effectively controlled asthma attack, with significant differences in the therapeutic effects (P>0.05). In contrast, only a few children showed improvement in group B, suggesting the ineffectiveness of the treatment.</p><p><b>CONCLUSION</b>Nebulized medicine is one of the best means for management of acute asthma exacerbation in children, and inhalation of budesonide suspension plus salbutamol and ipratropium bromide can effectively relieve the asthmatic symptoms in these children with good compliance and convenient administration.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Acute Disease , Aerosols , Albuterol , Therapeutic Uses , Asthma , Drug Therapy , Bronchodilator Agents , Therapeutic Uses , Budesonide , Therapeutic Uses , Drug Therapy, Combination , Ipratropium , Therapeutic Uses , Treatment Outcome
10.
Journal of Southern Medical University ; (12): 1612-1613, 2007.
Article in Chinese | WPRIM | ID: wpr-283073

ABSTRACT

<p><b>OBJECTIVE</b>To assess the value of immunoregulants in improving the prognosis of infants with wheezing.</p><p><b>METHODS</b>Forty-three infants with wheezing with given oxygen support, injection or inhalation of glucocorticosteroids or bronchodilatator to relieve the symptoms. Of these infants, 24 received immunoregulant treatment with bronchovaxom at the daily dose of 3.5 mg for 10 days every a month for a treatment course of 3 months. The other 19 infants were managed with budesonide aerosol at 200 microg once or twice daily for 3 months (basic treatment group). All the infants were followed up for 1 year to record the number of wheezing episode and infections. Ten healthy infants were also included in this study as the control group.</p><p><b>RESULTS</b>In infants with bronchovaxom treatment, 25% reported more than 3 wheezing episodes within the 1-year follow-up, a rate significantly lower than that in the control group (63.2%, Chi(2)=6.344, P<0.05). The episodes of respiratory infection were similar between bronchovaxom group and the healthy control group (t=0.72, P>0.05), but significantly higher in the basic treatment group than in bronchovaxom and the healthy control group (t=3.11 and 3.92, respectively. P<0.05).</p><p><b>CONCLUSIONS</b>Bronchovaxom can effectively reduce the recurrence of wheezing and respiratory infections in the infants with wheezing attack to reduce the risks of asthma development.</p>


Subject(s)
Child, Preschool , Female , Humans , Infant , Male , Asthma , Diagnosis , Drug Therapy , Bacteria , Cell Extracts , Follow-Up Studies , Immunologic Factors , Therapeutic Uses , Prognosis , Respiratory Sounds
11.
Chinese Journal of Experimental and Clinical Virology ; (6): 361-363, 2007.
Article in Chinese | WPRIM | ID: wpr-248753

ABSTRACT

<p><b>OBJECTIVE</b>To investigate changes in the levels of Th2 cytokine interleukin-4 (IL-4), Th1 cytokine interferon-gamma (IFN-gamma), and TNF-alpha in serum of newborn infants with cytomegalovirus (CMV) pneumonia.</p><p><b>METHODS</b>Twenty-five neonatal cases who were positive for serum IgM antibody to CMV by ELISA were divided into IVIG intervention group and ganciclovir intervention group, and 15 healthy neonates were enrolled into the control group. The levels of IL-4, IFN-gamma, and TNF-alpha were detected by using double antibody ELISA for the control group and the intervention groups at the beginning and end of treatment.</p><p><b>RESULTS</b>The levels of IFN-gamma and TNF-alpha in patients with CMV pneumonia were higher than that in the healthy neonates, while the levels of IL-4 were lower(t= 2.65 and 3.16, p less than 0.05). The level of IL-4 in patients with CMV pneumonia was significantly lower than that of the healthy neonates (t= 2.49, p less than 0.05). There was no significant difference in the levels of IFN-gamma, IL-4 and TNF-alpha between IVIG intervention group and ganciclovir intervention group at the beginning of treatment (t= 1.85, 1.71, 1.76, p greater than 0.05). In IVIG intervention group, the levels of IFN-gamma and TNF-alpha significantly decreased after treatment (t=3.98, 5.16, p less than 0.01), the level of IL-4 in this group was higher than that before treatment (t= 2.55, p less than 0.05). In ganciclovir group, the level of IFN-gamma and TNF-alpha did not change after treatment (t=1.75, 1.16, p greater than 0.05), the level of IL-4 in this group was higher than that before treatment (t= 2.39, p less than 0.05).</p><p><b>CONCLUSION</b>There seems to be an imbalance of Th1 and Th2 cytokines secretion in the infants with CMV pneumonia and, which may lead to immune-inflammation injury. IVIG can regulate imbalanced Th1/Th2 activities, therefore, immunomodulatory treatment should be applied besides antiviral therapy.</p>


Subject(s)
Female , Humans , Infant, Newborn , Male , Cytokines , Blood , Cytomegalovirus Infections , Allergy and Immunology , Interferon-gamma , Blood , Interleukin-4 , Blood , Pneumonia, Viral , Allergy and Immunology , Th1 Cells , Allergy and Immunology , Th2 Cells , Allergy and Immunology , Tumor Necrosis Factor-alpha , Blood
12.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 273-276, 2007.
Article in Chinese | WPRIM | ID: wpr-262887

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the effect of induction chemotherapy on the patients with moderate tongue squamous cell carcinoma and to investigate the factors that influence prognosis of these patients.</p><p><b>METHODS</b>One hundred and twenty two patients with moderate tongue squamous cell carcinoma (stage II-III, T2-3 N0/T1-3N1), treated from Jan. 1990 to Dec. 1999 were retrospectively reviewed. Among them, 69 and 53 patients were received operation alone and operation after induction chemotherapy respectively [cisplatin + 5-fluorouracil + bleomycin-A5 (PBF), 17 cases; bleomycin-A5, 36 cases]. Survival rate was estimated by Kaplan-Meier method. Multivariate analysis by the Cox proportional hazard model.</p><p><b>RESULTS</b>The mean follow-time of all patients were (79.9 +/- 49.8) (x +/- s) months (range: 7 to 177 months), and 45 patients died (including 5 lost to follow up) , 66 of 77 patients alive followed more than 5 years. The overall 3-year and 5-year survival rate were 79.4% and 69. 0% respectively. The overall 3-year and 5-year free-disease survival rate were 71.7% and 66. 3% respectively. The survival rate of 3-year and 5-year was 82.5% and 73.1% respectively for the group of operation alone; 82.4% and 70.1% respectively for the group of operation after induction chemotherapy with PBF, 72.2% and 61.1% respectively for the group of operation after induction chemotherapy with bleomycin-A5; and there were no significant difference between the above three groups (chi2 = 0.42, P = 0.8106). The locoregional recurrence rate were 30.4%, 41.2% and 38.9% for the operation alone group, operation after PBF induction chemotherapy group and operation after bleomycin-A5 induction chemotherapy group respectively. No significant benefit on decreasing locoregional recurrence (chi2 = 1.148, P = 0.563) or distant metastasis rate (chi2 = 2.305, P = 0.316) were found by induction chemotherapy by univariate analysis. Using multivariate analysis, risk factor that independently influence survival was the recurrence.</p><p><b>CONCLUSIONS</b>Risk factors that independently influence survival of moderate tongue squamous cell carcinoma was the locoregional recurrence. No significant benefit on improving survival rate or decreasing locoregional recurrence or metastasis rate were found by induction chemotherapy, there was no difference between the two induction chemotherapy schemes on the survival rate or locoregional recurrence or metastasis rate of these patients.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Carcinoma, Squamous Cell , Drug Therapy , Mortality , Pathology , Chemotherapy, Adjuvant , Neoplasm Staging , Prognosis , Retrospective Studies , Risk Factors , Survival Rate , Tongue Neoplasms , Drug Therapy , Mortality , Pathology
13.
Chinese Journal of Experimental and Clinical Virology ; (6): 132-134, 2007.
Article in Chinese | WPRIM | ID: wpr-248825

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of leukotriene receptor antagonist on the levels of Th1 and Th2 cytokines and the serum cysteinyl leukotrenes (CysLTs) in infants and young children with respiratory syncytial virus (RSV) pneumonia.</p><p><b>METHODS</b>Thirty-seven infants and young children with RSV pneumonia were divided into two groups after discharge. The cases in group 1 (n=24) were treated with a leukotriene receptor antagonist, Singulair 4 mg once daily for 12 weeks; the cases in group 2 (n=13) were treated with budesonide aerosol 200 ug once or twice daily for 12 weeks. The serum CysLTs, IFN-gamma and IL-4 were detected with enzyme_linked immunosorbent assays (ELISA) for all the 37 cases, and 10 healthy infants of the same age served as controls.</p><p><b>RESULTS</b>The serum CysLTs level in the cases with RSV pneumonia was significantly higher than that in controls (P<0.05). There was an imbalance in expression of Th1 and Th2 cytokines (IFN-gamma and IL-4 ) in these cases. Both Singulair and budesonide aerosol could correct the imbalance of Th1 and Th2 cytokines. The serum CysLTs level declined after treatment with Singulair in 24 cases, but no significant change occurred after treatment with budesonide aerosol in the remaining 13 cases.</p><p><b>CONCLUSIONS</b>The serum CysLTs level in children with RSV pneumonia was higher than that in healthy children, and there was an imbalance of Th1 and Th2 cytokines in these infants, which was similar to those with asthma. Leukotriene receptor antagonist may be effective in preventing children with RSV pneumonia from evolving into asthma.</p>


Subject(s)
Child, Preschool , Female , Humans , Infant , Male , Cytokines , Blood , Leukotriene Antagonists , Pharmacology , Pneumonia, Viral , Drug Therapy , Allergy and Immunology , Virology , Respiratory Syncytial Virus Infections , Drug Therapy , Allergy and Immunology , Virology , Respiratory Syncytial Viruses , Allergy and Immunology , Th1 Cells , Allergy and Immunology , Th2 Cells , Allergy and Immunology
14.
Chinese Journal of Experimental and Clinical Virology ; (6): 279-281, 2007.
Article in Chinese | WPRIM | ID: wpr-248778

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of polysaccharide nucleic acid of BCG (BCG-PSN) injection on immune and pulmonary function in asthmatic children complicated with allergic rhinitis.</p><p><b>METHODS</b>Thirty-seven cases were separated at random into two groups, the BCG-PSN group (17 cases) was treated with BCG-PSN plus inhaled glucocortisteriods, and the control group (20 cases) was treated with inhaled glucocortisteriods only. The children in both groups were followed up for 6 months to record their lung function, allergic rhinitis scores, frequency of asthmatic attacks and respiratory infection. The levels of interleukin (IL)-4, interferon-gamma (IFN-g) and plasma total IgE were detected by using double antibody sandwich ELISA at the beginning and the end of treatment.</p><p><b>RESULTS</b>In comparison with the control group, after treatment, the levels of IFN-g and the ratio of IFN-g/IL4 in the BCG-PSN group significantly increased, whereas the level of IL-4 and the plasma total IgE significantly decreased (P less than 0.05), while those of the control group had no significant change. The lung function of both groups had significant improvement (p less than 0.05). The frequencies of asthmatic attacks in BCG-PSN and control groups were 0.81 +/- 0.20 vs. 1.72 +/- 0.80, and the difference was statistically significant. The frequencies of respiratory tract infection in BCG-PSN and control groups were 1.15 +/- 0.55 vs. 3.21 +/- 0.73, the difference was significant.</p><p><b>CONCLUSION</b>BCG-PSN may be able to correct the imbalance of Th1/Th2 and improve the lung function of children with asthma complicated with allergic rhinitis, which suggest that the immune adjusting treatment should be emphasized besides anti-inflammation therapy.</p>


Subject(s)
Adolescent , Child , Child, Preschool , Female , Humans , Male , Adjuvants, Immunologic , Chemistry , Therapeutic Uses , Asthma , Blood , Drug Therapy , BCG Vaccine , Chemistry , Therapeutic Uses , Enzyme-Linked Immunosorbent Assay , Methods , Interferon-gamma , Blood , Interleukin-4 , Blood , Nucleic Acids , Chemistry , Polysaccharides, Bacterial , Chemistry , Rhinitis, Allergic, Perennial , Blood , Drug Therapy , Treatment Outcome
15.
Chinese Journal of Stomatology ; (12): 650-653, 2006.
Article in Chinese | WPRIM | ID: wpr-293020

ABSTRACT

<p><b>OBJECTIVE</b>To compare the results of different treatment modalities for the advanced tongue squamous cell carcinoma and investigate the factors that influence its prognosis.</p><p><b>METHODS</b>Ninety-two patients with advanced tongue squamous cell carcinoma without distant metastasis, treated in our hospital from Jan. 1990 to Dec. 1999 were retrospectively reviewed. Survival rate was estimated by Kaplan-Meier method, and multivariate analysis was performed by the Cox Proportional hazard model.</p><p><b>RESULTS</b>The overall 3-year and 5-year survival rates were 52.40% and 37.23% respectively. There was a significant difference in the overall between the two groups survival rate (chemotherapy only and radiotherapy after induced chemotherapy) and the three groups (operation only, operation after induced chemotherapy, radiotherapy after operation) cTNM stage, operation for the primary lesion and local recurrence were the independent factors that influenced the prognosis.</p><p><b>CONCLUSIONS</b>Risk factors that independently influence the survival of patients with advanced tongue squamous cell carcinoma were the local recurrence, cTNM and receiving operation or not for the primary lesion. Operation only or comprehensive therapy including operation could give a better prognosis, but the results of chemotherapy only or radiotherapy after chemotherapy were poor.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Combined Modality Therapy , Kaplan-Meier Estimate , Neoplasms, Squamous Cell , Pathology , Therapeutics , Prognosis , Proportional Hazards Models , Retrospective Studies , Tongue Neoplasms , Pathology , Therapeutics
16.
Chinese Journal of Surgery ; (12): 1493-1497, 2006.
Article in Chinese | WPRIM | ID: wpr-288562

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the treatment model and the factors that influence survival of the patients with anaplastic thyroid carcinoma (ATC).</p><p><b>METHODS</b>The clinical data of all patients with ATC in our hospital from May. 1970 to May. 2005 were analyzed retrospectively with regard to mortality and survival rate (Kaplan-Meier). Multivariate analysis was performed by the Cox proportional hazard model.</p><p><b>RESULTS</b>Fifty cases together were analyzed. The overall 1-year, 3-year, 5-year survival rate were 39.4%, 29.6% and 20.7% respectively. The median survival time was 6 months. Univariate analysis showed the patients with their age < 55 years old, without distant metastasis, white blood cell count < 10.0 x 10(9)/L at presentation, without receiving chemotherapy, receiving radiotherapy with the dose no less than 40 Gy, receiving multiple modality therapy had a better prognosis. White blood cell count at presentation, the model of therapy were the risk factors independently influencing prognosis by multivariate analysis.</p><p><b>CONCLUSIONS</b>White blood cell count at presentation, receiving surgery and postoperative radiotherapy or not were the risk factors independently influencing prognosis. The prognosis of anaplastic thyroid carcinoma was worse; the patients with ATC maybe get a better prognosis by receiving surgery and postoperative radiotherapy.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Carcinoma , Diagnosis , Therapeutics , Follow-Up Studies , Kaplan-Meier Estimate , Prognosis , Retrospective Studies , Thyroid Neoplasms , Diagnosis , Therapeutics , Treatment Outcome
17.
Chinese Journal of Oncology ; (12): 938-941, 2006.
Article in Chinese | WPRIM | ID: wpr-316262

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical characteristics and prognosis of second primary tumor of tongue (SPTr) after nasopharyngeal carcinoma (NPCR) treated with radiotherapy.</p><p><b>METHODS</b>Clinical data of 53 patients with SP7T after NPCR (group A) and 252 patients with primary tongue carcinoma (group B) were analyzed retrospectively with regard to clinical characteristics and survival rate (Kaplan-Meier); and multivariate analysis was performed using Cox proportional hazards model.</p><p><b>RESULTS</b>There was no significant difference between group A and group B ( P > 0. 05) in the presenting age, sex, tumor size, cTNM stage, tumor differentiation and the rate of distant metastasis. The overall 5-year survival rates were 41.6% in group A and 56.3% in group B (chi2 = 4.40, P = 0.0359) with a statistically significant difference between two groups. The differences of tumor location (chi2 = 61.18, P = 0.000) and rate of clinical (cN+, chi2 = 6.846, P = 0.009) or pathological lymph node metastasis (pN+, X2 = 3.993, P = 0.046) were also statistically significant between group A and group B, respectively. Multivariate analysis showed that age at presence, cTNM stage and with or without neck lymph node dissection were independent risk factors affecting survival.</p><p><b>CONCLUSION</b>Second primary tongue carcinoma after radiotherapy for nasopharyngeal carcinoma is likely to occur on the dorsal aspect of the tongue with worse prognosis but with a lower rate of lymph node metastasis than that of primary tongue carcinoma. However, radiotherapy history is not an independent influencing factor on prognosis. Surgical resection or combined modality therapy may give a better prognosis.</p>


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Antineoplastic Agents , Therapeutic Uses , Combined Modality Therapy , Follow-Up Studies , Glossectomy , Methods , Kaplan-Meier Estimate , Lymphatic Metastasis , Multivariate Analysis , Nasopharyngeal Neoplasms , Radiotherapy , Neck Dissection , Neoplasms, Radiation-Induced , Pathology , Therapeutics , Neoplasms, Second Primary , Pathology , Therapeutics , Prognosis , Proportional Hazards Models , Radiotherapy , Retrospective Studies , Tongue Neoplasms , Pathology , Therapeutics
18.
Chinese Journal of Otorhinolaryngology Head and Neck Surgery ; (12): 819-823, 2005.
Article in Chinese | WPRIM | ID: wpr-239126

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the clinical characteristics of second primary tumor of tongue after nasopharyngeal carcinoma (NPC) radiotherapy and the prognostic factors of patients.</p><p><b>METHODS</b>Fifty-three cases with second primary tumor of tongue after NPC radiotherapy, presenting to Cancer Centre, Sun Yat-sen University from Jan. 1st 1975 to Dec. 31st 2000 were analyzed retrospectively with regard to mortality and survival rate (Kaplan-Meier method); A multivariate analysis was performed in these patients with Cox proportional hazard model.</p><p><b>RESULTS</b>Forty of 53 patients died. Among them,37 died of second primary tumor of tongue, 2 of recurrence of NPC, 1 of perioperative period. The overall 5-year and 10-year survival rate of 51 patients receiving therapy were 41.64% and 35.69% respectively. The subsites of tumor were: tip 0, margin 26 (49.06%), ventral lateral 8 (15.09%) and dorsal aspect 19 (35.85%). Eighteen cases had recurrence of second primary tumor of tongue (33.96%) ; Six (11.32%) cases had clinical lymph node metastasis from second primary tumor of tongue and 3 (5.66%) had pathological lymph node metastasis; The univariate analysis showed the major prognostic factors influencing survival of these patients were tumor size, clinical TNM stage at presentation; Using multivariate analysis, risk factors that independently influence survival were clinical and pathological stage and the interval between two tumors.</p><p><b>CONCLUSIONS</b>The clinical and pathological stage and the interval between two tumors are the prognostic factors for second primary tumor of tongue after NPC radiotherapy.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Carcinoma , Mortality , Pathology , Radiotherapy , Carcinoma, Squamous Cell , Nasopharyngeal Neoplasms , Mortality , Pathology , Radiotherapy , Neoplasms, Second Primary , Prognosis , Retrospective Studies , Survival Rate , Tongue Neoplasms
19.
Chinese Journal of Experimental and Clinical Virology ; (6): 127-128, 2004.
Article in Chinese | WPRIM | ID: wpr-281837

ABSTRACT

<p><b>BACKGROUND</b>To investigate the prevalence of anti-HEV among swine, sheep and chickens.</p><p><b>METHODS</b>Totally 498 sera of swine, sheep and chickens collected from Xingjiang, Guangxi, Guangdong, Beijing and Hebei were detected for the anti-HEV by an enzyme linked immunoassay.</p><p><b>RESULTS</b>The anti-HEV positive rate of swine was 67.53%(104/154), in pigs between 4-5 months of age the rate was 100.00%(9/9) from Xingjiang. The rate in pigs under 3 months of age from Guangxi was 36.00%(9/25) and in pigs older than six months of age was 71.67% (86/120), respectively. The 108 sera of sheep collected from Xingjiang were all negative. The positive rate of chickens was only 1.27% (3/236). The anti-HEV prevalence rates of chickens from Luoding, Shenzhen, Liuzhou, Beijing and Hebei were 4.00%, 1.49%, 1.49%, 0, 0 respectively.</p><p><b>CONCLUSION</b>HEV infection does exist among swine and chickens. The anti-HEV prevalence of swine was the highest among domestic animals. The role of swine and chickens in transmission of HEV needs to be further studied.</p>


Subject(s)
Animals , Antibodies, Viral , Chickens , China , Epidemiology , Hepatitis Antibodies , Blood , Hepatitis E , Epidemiology , Hepatitis E virus , Allergy and Immunology , Poultry Diseases , Epidemiology , Virology , Prevalence , Sheep , Sheep Diseases , Epidemiology , Virology , Swine , Swine Diseases , Epidemiology , Virology
20.
Chinese Journal of Hepatology ; (12): 405-407, 2003.
Article in Chinese | WPRIM | ID: wpr-305917

ABSTRACT

<p><b>OBJECTIVES</b>To investigate HEV infection in swine and the genotype relationship between swine and human HEV.</p><p><b>METHODS</b>Anti-HEV IgG antibody was detected in the sera of swine using enzyme linked immunoassay (EIA), and HEV RNA was amplified by reverse transcription nested polymerase chain reaction (RT-nPCR). The Vector NTI Suite 7 and TreeView softwares were used for nucleotide sequences phylogenetic analysis of HEV isolated from human and swine.</p><p><b>RESULTS</b>The anti-HEV IgG positive rate was 16.67% (18/108). Among the 18 anti-HEV IgG positive sera, 2 sequences (11.11%, called S18 and S43, respectively) of HEV ORF1 (102-387bp) were amplified, with the identity of 99% between them. They had 76% to 77%, 78%, 76% to 79%, 85% to 86%, 77%, 80%, 79% and 75% - 79% homology at the nucleotide level with human HEV genotypes 1 to 8, respectively. One (S18) of them was also amplified out in ORF2 region (5,994-6 297bp) and showed 76% to 78%, 74%, 74% to 77%, and 85% to 94% identity with human HEV genotypes 1 to 4 at the nucleotide level, respectively.</p><p><b>CONCLUSION</b>HEV sequences isolated from swine belong to human HEV genotype 4.</p>


Subject(s)
Animals , Antibodies, Viral , Blood , Base Sequence , Hepatitis E , Hepatitis E virus , Classification , Genetics , Immunoglobulin G , Blood , Molecular Sequence Data , RNA, Viral , Chemistry , Reverse Transcriptase Polymerase Chain Reaction , Swine , Swine Diseases , Virology
SELECTION OF CITATIONS
SEARCH DETAIL